Approach

We do the work.

Not another slide deck of recommendations. An operating team that installs the engine, runs it with you, and hands you something that keeps working.

Principles

How we operate.

Operators, not observers

We have sold and deployed health-innovation products and raised capital. We carry a bag, run the deal reviews, and sit in the buyer meetings.

Founder-led by design

Early sales belong to founders. We build the engine around you and make you dangerous in the room, instead of renting you a sales team you cannot keep.

Evidence over opinion

Pilots designed to produce proof. Outcome measures buyers care about. References harvested from every win.

The engagement

Four moves, in order.

01

Diagnose

Where the pipeline, positioning, and evidence actually stand. A blunt read on what Series A requires from here, and what it does not.

02

Install the engine

GTM plan, playbooks, and systems in the first 60 days. The machinery your team will still be using two years from now.

03

Sell alongside you

Discovery calls, pilots, procurement, references. We run the motion with you until conversion is repeatable and the unit economics hold.

04

Position the raise

Milestones, narrative, and data room built from the traction. The round gets priced on evidence you now own.

The map

Integrated with your capital raise.

An integrated approach with capital raising ensures you are positioned for the best execution on Series A.

Pre-Revenue

Build the foundation
  • Product proof
  • First believers

Series A Milestones

Founder-led sales to fast-track product-market fit
  • High conversion with early adopters
  • Scalable unit economics
  • Customers who have room to grow
  • 3+ customers, $3M to $5M revenue

Series B Milestones

It's go time
  • Sales leader hired, team expanded
  • Land and expand within initial customers
  • 10+ customers, $10M to $15M revenue
Selectivity

We take on few engagements, deliberately.

Embedded work does not scale like an agency. Fit matters more than volume, on both sides.

A strong fit

  • Funded health-innovation company between first pilots and roughly $20M revenue
  • Founders who can sell, inspire, and want to learn the commercial motion
  • A product with real clinical or economic evidence behind it, or a credible path to it
  • International teams with proven products entering North America

Not a fit

  • Pre-product teams still searching for what to build
  • Companies looking for a lead-generation vendor rather than an operating partner
  • Teams that want validation instead of a blunt read
  • Engagements where we cannot work directly with the founders
The odds

Most start-ups never raise a Series A. Yours does not have to be one of them.

Next step

Bring us your pipeline. We will tell you what Series A requires from here.

info@sksgrowthpartners.com